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REPORT OF THE SCIENTIFIC VETERINARY COMMITTEE, SCIENTIFIC COMMITTEE 
FOR ANIMAL NUTRITION AND THE SCIENTIFIC COMMITTEE FOR FOOD ON 
THE BASIS OF THE REPORT OF THE SCIENTIFIC GROUP ON 
ANABOLIC AGENTS IN ANIMAL PRODUCTION 
I. INTRODUCTION 
On the 31 July 1981 the Council adopted Directive 81/602/EEC concer-
ning the prohibition of certain substances having a hormonal action and 
of any substance having a thyrostatic action. 
By Article 5 of that Directive the Council decided to take a decision as 
soon as possible on the administering to farm animals of oestradiol \1p>, 
testosterone, progesterone, trenbolone and zeranol, for fattening purpo-
ses. It also noted the Commissions intention to consult the competent 
Scientific Committees on the matter. 
The Commission asked the Scientific Veterinary Committee, the Scientific 
Committee for Animal Nutrition and the Scientific Committee for Food the 
question : 
"Does the use for fattening purposes in animals of the following 
substances : oestradiol - Yl/*, testosterone, progesterone, trenbolone 
and zeranol present any harmful effect to health." 
To facilitate this work, a specific Scientific Group was created in which 
representatives of each of the Scientific Committees participated. 
This document contains the report adopted by the Scientific Group as a 
result of its final meeting of 22.9.1982. This report was made available 
to the Scientific Committees whose opinion was requested. 
The Scientific Veterinary Committee gave its opinion at its meeting on 
9.11.1982. 
The Scientific Committee on Animal Nutrition gave its opinion at its 33rd 
meeting on 17.11.1982. 
The Scientific Committee for Food gave its opinion at its 39th meeting on 
4.02.1983. 
(1) OJ No L 222 of 07.08.1981, p. 32 
II. REPORT OF THE SCIENTIFIC GROUP ON ANABOLIC AGENTS IN ANIMAL PRODUCTION 
COMPOSITION OF THE SCIENTIFIC GROUP 
G. BALLARINI 
E. BEAULIEU 
G. POTTIE 
N. DEBACKERE 
P. ELIAS 
J. FALCK-LARSEN 
R. FERRANDO 
G. GATTI 
R.J. HEITZMAN 
Β. HOFFMANN 
Η. KARG 
Η. KUIPER 
G.E. LAMMING (CHAIRMAN) 
G. MICHEL 
G. MOUTHON 
E. POULSEN 
A. RICO 
F. SCIARRA 
C. SKOUNTZOS 
F.X.R. VAN LEEUWEN 
D. WHITE 
V. WYNN 
Β. REPORT 
1. INTRODUCTION 
The Council Directive 81/602/EEC concerning the use of certain 
substances having a hormonal action and of any substances having a 
thyrostatic action stipulates in Article 5 that the Council would as 
soon as possible take a decision on the use of oestradiol-17/^ , 
progesterone, testosterone, trenbolone and zeranol for the fattening 
of farm animals. For this purpose the Commission was required to 
present to the Council, a report on the collected experience and 
scientific developments in this field. Consequently a Scientific 
Working Group was set up to advise the Commission of the European 
Communities on whether the use of oestradiol-17/? , testosterone, 
progesterone, trenbolone and zeranol as anabolic agents in animal 
production was a risk to public health. 
The Terms of Reference of the Scientific Working Group were as 
follows: -
"Does the use for fattening purposes in animals of the following 
substances: oestradiol-17/^, testosterone, progesterone, trenbolone 
and zeranol present any harmful effect to health?" 
In framing its advice, the Scientific Working Group considered the 
2) guidelines prepared by the Scientific Committee for Food , the 
3) Scientific Committee for Animal Nutrition and the Council Direct-
4) ives on Veterinary Medicinal Products (81/851/EEC and 81/852/EEC) . 
The Working Group decided: 
a) that the most suitable criteria for assessing the safety of anabo­
lic agents (growth promoters) were those set out in Part 2, 
Chapter I, Section Α-D of the Annex of Directive 81/852/EEC of 28 
September 1981 on the approximation of laws of the Member States 
relating to analytical, pharmaco-toxicological and clinical 
standards and protocols in respect of testing of veterinary medi­
cinal products. 
b) that safety is related to the conditions of use of anabolic agents. 
(1) OJ L 222 of 7. 8.1981, p. 32 
(2) Reports of the Scientific Committee for Food (EUR 6892) 10th Series 
(3) Reports of the Scientific Committee for Animal Nutrition (1980 EUR 6918) 
(4) OJ L 317 of 6.11.1981, p. 1 and 16 
The Scientific Working Group gave special consideration to a number 
of general points, such as the need to protect those segments of the 
population, e.g. prepubertal children, which were most likely to be 
affected from the toxicological point of view; the distribution of 
residues in edible tissues; the conditions of use of anabolic agents 
for growth promotion and improved feed conversion in relation to the 
general food supply; the need to avoid illegal use; and the 
importance of providing sensitive and accurate monotoring procedures 
on which to base enforcement of compliance with regulations. 
Enforcement of proper conditions of use is essential for safeguarding 
the consumer. 
In the opinion of the Scientific Group the appropriate conditions of 
use include 
a) the site of application should be discardable, 
b) the withholding periods must be observed. 
Anabolic sex hormones like oestradiol-17^ , testosterone, progestero-
ne, trenbolone and zeranol lead to an increased feed conversion and 
hence protein deposition in farm animals. The basic mechanisms of 
action on the molecular level are not completely understood. However, 
there is increasing evidence that the effects are mediated through 
the basic hormone-receptor interactions. The food of animals, includ-
ing man, normally contains natural substances with hormonal activity. 
No side effects on animal health have been reported following the 
recommended use of these materials in growing animals other than 
those related to their hormonal effects on behavior and the reproduc-
tive system. Behavioral problems may occur during the first few weeks 
following treatment but with careful management these problems are 
not difficult to overcome. The use of anabolic agents to promote 
growth in animals intended for breeding is contraindicated because of 
their adverse effects on the reproductive and endocrine systems. 
PRESENT SITUATION 
Based on previous safety evaluations some EEC member states have 
accepted the use of trenbolone and zeranol and of oestradiol-17/3 
progesterone and testosterone. 
The conditions of use require the drug to be implanted at a site (ear 
or base of ear) which is discarded at slaughter. Withholding periods 
have to be observed and doses applied per animal range from 20-40 mg 
for oestradiol-17/^ and zeranol, *<- 200 mg for progesterone and 
testosterone and 140-300 mg for trenbolone in the form of its acetate. 
Council Directive 81/602/EEC of 31 July 1981 prohibits the placing on 
the market of stilbenes, stilbene derivatives, their salts and esters 
and thyrostatic substances for administering to animals of all 
species. 
The Committee did not consider the consequences on the quality of 
meat of the use of anabolic substances. 
3. ENDOGENEOUS SEX STEROIDS : 0ESTRADI0L-17/fi> , TESTOSTERONE AND 
PROGESTERONE 
The Scientific Working Group considered that evaluation of the 
safety-in-use of oestradiol-17¿5 , testosterone and progesterone 
included consideration of those derivatives which readily yield the 
parent compound on hydrolysis after absorption from the site of 
application. 
Physiologically the steroidal sex hormones oestradiol-17/3 and 
testosterone as well as the gestagen progesterone control the proper 
function of the sexual physiology and "anabolism" in man and animals. 
The sex hormones are secreted by the gonads, the adrenals, and the 
placenta, the level of secretion being controlled by a complex but 
well established feedback mechanism. Sex steroids exert their hormo-
nal effects at target tissues by binding to highly specific receptor 
proteins. 
Because these compounds occur naturally they have to be considered as 
inevitable constituents of food from animal origin. Hormone levels in 
untreated animals vary widely depending on species, sex and physiolo-
gical state, eg. adult male cattle produce 40-50 mg testosterone/24 
h, cattle in late pregnancy several hundred milligrams of 
oestrogens/day. Thus the highest tissue levels of androgens are found 
in the mature male animal and of oestrogens in females during the 
later stages of pregnancy. 0estradiol-17¿3 , testosterone and 
progesterone also occur normally in milk in varying amounts depending 
on the physiological state of the animal. In man and animals endoge-
nous sex hormones are rapidly metabolised predominantly in the 
liver to compounds exerting only little, if any, biological activity. 
A large percentage of these metabolites is excreated directly in the 
bile following conjugation (glucuronide, sulphate). However, because 
of systemic circulation, metabolites (both free and conjugated) may 
be found in the tissues, particularly in the kidney and liver. 
Because there is a natural endogenous production of oestradiol-17/>' , 
progesterone and testosterone in all farm animals, any residues of 
these steroids are qualitatively indistinguishable from those derived 
from the use of these same steroids as anabolic agents administered 
to animals during life. Under appropriate conditions the treatment of 
animals with exogenous natural steroids results in residues in edible 
tissues which are orders of magnitude lower than those that can occur 
naturally in mature males, females and pregnant females. Therefore in 
practice no quantitative differences have been observed between 
treated and untreated animals when the recommended conditions of use 
were observed. Levels in treated and untreated calves are of the 
order of 0.1 ug testosterone/kg and 0.03 jig natural oestrogens/kg 
edible tissues. 
No problems arise concerning contamination of the environment as a 
result of the administration of endogenous hormones, given the natu­
ral background of these substances and their biodegradability. 
Levels and production rates of endogenous natural sex hormones vary 
in humans with age, state of sexual maturity, menstrual cycle and 
pregnancy. Daily production of oestrogens in infants ranges from 
1-40 ug, in man from 40-130 μ&, in women during reproductive life 
from 50-450 μg, in menopausal women from 5-40 ug. Daily production of 
testosterone in infants is about 100 μ%, in man 4-10 mg, and in women 
120-300 _ug. 
In relation to the endogenous sex steroid production in the human, 
the actual amount of sex steroids consumed with food of animal origin 
is toxicologically negligible as these steroidal residues do not 
reach effective concentrations at the relevant hormone receptor sites 
in target tissues. Moreover, the low oral bioavailability (less than 
15 %) of these steroids and the existing tissue barriers in the liver 
and placenta effectively prevent any adverse toxicological effects 
from the ingestion of the minute residues of natural sex steroids 
which may be present in all edible tissues of animals treated with 
anabolic hormones. Thus no questions of safety arise in relation to 
the proper use of oestradìo\-Ylß> , progesterone and testosterone in 
an appropriate form of preparation. 
4. EXOGENOUS ANABOLIC AGENTS 
4.1. Trenbolone (17-/9 hydroxy trenbolone) 
Trenbolone is a synthetic steroid with androgenic activity similar to 
testosterone but with greater anabolic activity. It has several 
structural features similar to testosterone but unlike testosterone, 
it has three conjugated double bonds, and is chemically less stable. 
The material normally in commerce is trenbolone acetate. 
Metabolism and Residues 
The metabolism of trenbolone acetate has been studied in the rat, 
calf, heifer, cow and steer. Trenbolone acetate is rapidly hydrolysed 
to trenbolone, and both trenbolone and its metabolites are rapidly 
excreted as the glucuronides and sulphates, mostly in the bile. The 
predominant metabolites identified in the extractable fractions of 
bile in the rat are trenbolone and a 16-OH and a 17-keto metabolite; 
while in cattle it is mainly 17i('-hydroxy trenbolone with small 
amounts of trenbolone and other metabolites. Many of the minor 
metabolites have been identified in both species. The parent compound 
and its metabolites have low oral activity. 
Following the recommended use of trenbolone acetate in cattle and the 
application of various methods of assay (radioimmunoassay, thin-layer 
and high performance liquid chromatography) the main metabolite found 
in muscle has been shown to be trenbolone «0.5 ppb muscle) and in 
liver and kidney a conjugated form at 175f hydroxy trenbolone (< 3 ppb). 
17^-hydroxy trenbolone has a biological activity at least 10 times 
less than 17/3 hydroxy trenbolone. 
Similarly following subcutaneous implantation of cattle with trenbo-
lone radiolabelled with tritium, total residues, expressed as 
-9 trenbolone equivalents, were a few parts per billion (10 ) in 
muscle and approximately 10 times higher in liver and kidney (5-35 
ppb). 5-10 X of the total residues labelled with tritium are 
extractable from meat, liver or kidney, and have been identified as 
similar to those found in bile. The identity of the remaining 
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unextractable residues, labelled with tritium, which are most likely 
irreversible bound, is not known but some tritium is found in the 
body water. The bioavailability of these unextractable residues in 
liver, kidney and muscle, following ingestion in rat feeding studies 
was found to be <Ίθ %. 
Toxicity studies. Acute toxicity studies in several species showed 
trenbolone to be of low oral toxicity. 
In subchronic toxicity studies trenbolone acetate was administered 
for 8 weeks in the diet of mice without any significant changes apart 
from those related to hormonal activity, which were still present at 
25 mg/kg diet, the lowest level tested. Similar subchronic studies in 
normal male and female rats and in castrated male rats, extending 
from 10 days to 3 months, showed increased size of liver, kidney and 
spleen at high doses and the expected hormonal changes down to dose 
levels of 50 ug/kg bodyweight. A 14 weeks oral feeding study in pigs 
produced increased liver weight and liver cell size in females at 
levels of 2 and 20 mg/kg diet. At the lowest dose level of 100 ug 
trenbolone acetate/kg diet tested there was no clear absence of a 
lack of a hormonal effect. 
A life-span feeding study in the mouse (dose range 0.5-100 mg/kg 
diet) extended over about 100 weeks. There was some increase in 
kidney weight at the highest dose levels in females sacrificed at 13 
weeks, an effect typical of androgenic activity. At terminal sacrifi­
ce no organ weights were recorded, but there was an increased incide­
nce of liver nodular hyperplasia and tumours in males of all dose 
groups which reached significance at the two highest dose levels and 
for females at the highest dose level tested. The control mice also 
had a high incidence of liver tumours. 
Female rats were administered with trenbolone acetate during 
pregnancy and the pups used in a 112 week feeding study, using doses 
of 0.5-50 mg/kg diet. A number of mild toxic changes were seen at the 
highest dose level. A clear cut no-effect level for hormonal activity 
could not be determined. However, the data indicated that (since the 
lowest dose group showed no significant changes in all parameters 
examined compared to controls) a concentration of 0.5 ppm in the diet 
(25 ^ g/kg B.W.) is the probable "no-hormonal effect level" for the 
rat. This result requires confirmation. An increased (though not 
statistically significant) incidence of pancreatic islet cell tumours 
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was seen at the highest dose level (50 mg/kg diet). A one-generation 
reproduction study in rats, using 0.5-16 mg/kg diet in males and 
0.5-50 mg/kg diet in females showed a dose related effect on pregnancy 
rate and litter parameters. No teratogenic effect was seen in two feeding 
studies in rats. A relay toxicity study has shown that meat from cattle 
treated at doses 10-25 times greater than the normal doses for 
lT/^oestradiol and trenbolone acetate showed no effects in rats. 
Because of the irreversible binding of some residues to macromolecules, 
which may indicate a genotoxic potential, special attention was given to 
mutagenicity tests with trenbolone. 
Genotoxicity was examined by mutagenicity tests and by the capacity for 
DNA binding. Neither¿3 -Trenbolone norX -Trenbolone showed any mutagenic 
activity in prokaryotic systems nor in any in^  vivo test for bone marrow 
and germ cell cytogenetics. Clastogenic activity in vitro against human 
lumphocytes in culture were negative but tests against cells (L 5178 mouse 
lymphoma) were slightly positive, but to the same degree shown by 
testosterone and oestradiol. Concerning DNA binding in vivo in rats 
covalent binding indices were very low and equivalent for trenbolone and 
testosterone and less than for oestradiol. The data available to the group 
do not indicate any genotoxic activity. The question of binding to 
macromolecules other than DNA is a general problem which the group 
consider worthy of further study. 
The findings of the carcinogenicity studies in rodents are difficult to 
interpret because of the interference by the hormonal activity of the dose 
levels employed and the comparatively high incidence of liver tumours in 
the controls used in the mouse study. The results of the mutagenicity 
tests do not indicate genotoxic activity. Hence the increased tumour 
incidence observed at high dose levels is probably due to epigenetic 
mechanisms related to the modulating effect of the hormonal activity on 
the mechanism of tumour production. Therefore, further information on the 
"no hormonal effect" level of trenbolone acetate is necessary. 
The present information on the average daily consumption of muscle 
tissues and offals within the EEC suggest that the consumer would 
probably be exposed to similar amounts of 17j<.and 17^-hydroxy 
trenbolone through his food. Therefore more toxicological information 
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particularly the determination of the no hormone effect level of 
17^-hydroxy trenbolone is desirable. In summary for trenbolone, 
establishment of the no hormonal effect level of 17-/''and 17-IX 
trenbolone is required. Clarification is required of carcinogenicity 
data of 17/^ trenbolone particularly from the chronic toxicity study 
by taking into account the mutagenicity studies already completed. 
4.2. Zeranol 
This substance is structurally not a steroid and does not itself 
occur in nature although the parent substance zearalenonde is a 
natural substance elaborated by Gibberella Zea. It has oestrogenic 
and anabolic activity. 
Metabolism 
The metabolism has been studied in a number of species including 
cattle and sheep. Most of the orally administered substance is 
absorbed and eliminated in the faeces and urine. The proportions of 
urinary and faecal elimination is species dependent. 
Zeranol is excreted both as free and conjugated substance and as free 
and conjugated zeralanone. The same metabolites appear in the bile. 
Most of orally administered zeranol has practically disappeared from 
the tissues within 24 hours except for the liver and kidney, however, 
no thorough identification of the possible metabolites has been made 
in the relevant species. 
The oestrogenic properties were studied in many species using 
comparatively high doses but a no-hormonal effect level has not been 
determined, activity still being detectable at levels of 
30-50 jig/animal/day in rats and mice. However, in vitro assays point 
to zeranol having about 20 X of the oestrogenic activity of 
oestradiol. 
Toxicity 
Zeranol has a low acute oral toxicity in most species. Subchronic 
feeding studies for 13 weeks in the rat showed hepatotoxicity in both 
sexes and none of the doses was free from hormonal activity (lowest 
dose tested 0.25 mg/kg bodyweight). Feeding studies in dogs ranging 
from 6-104 weeks and over a wide range of doses showed some haemato-
logical effects at high dose levels andevidence of gross hormonal 
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effects at all levels tested. A no-hormonal effect level was not 
determined. 
A life span feeding study in rats over 2 years at dose levels from 
0.8-20 mg/kg bodyweight/day showed hormonal effects in males and 
females at all dose levels. Some haematological effects at the 
highest dose levels as well as microscopically detected hapatotoxici-
ty at all levels were noted. No carcinogenic effects were seen. 
A seven year study in female beagles showed variable toxic effects at 
the high dose level on the haemopoietic system with increased weights 
of liver, kidney and adrenals at all levels but also significant 
effects due to hormonal activities on all reproductive organs at both 
dose levels. Female beagles were hysterectomised. Although not 
specially designed for this purpose, no carcinogenic effects were 
seen. 
A ten year feeding study in female rhesus monkeys using a dose range 
of 15 and 75 mg/kg bodyweight showed some haematological changes at 
the highest dose level and alteration in hepatic function at both 
dose levels tested with increased liver weight at termination. Both 
dose levels showed significant hormonal effects on the reproductive 
system, hence a no-hormonal effect level was not determined. Although 
not specially designed for this purpose, no evidence of carcinogeni-
city was found. 
A three-generation reproduction study in rats combined with a 
teratology study showed no adverse effects at all levels up to 
200 ug/kg diet. Another teratology study in rats showed inhibition of 
implantation at the lowest dose tested (1 mg/animal/day during 1 to 4 
of gestation). A similar study in mice gave no effects on pregnancy 
and litter parameters at doses below 100 jug/kg bodyweight without 
showing any teratogenic effects. 
Mutagenicity was studied in prokaryotic systems but the toxicity of 
zeranol for the indicator organism made the study difficult to 
interpret. Low level exposures in these systems produced no mutagenic 
effects. 
In summary, although a large number of studies have been performed 
with zeranol, there are insufficient data on the nature of the 
metabolites, on the quantity and nature of the residues in the 
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edible tissues of animals and on mutagenicity to interpret the 
available information in terms of the safety or otherwise of zeranol. 
A sufficiently sensitive method for determining unlabelled zeranol in 
edible tissues is not available, although a satisfactory method is 
available for urine of cattle and sheep. There is not sufficient 
information about the chemical impurities of the commercial product. 
None of the experiments permit the establishment of a no-hormonal 
effect level necessary for the interpretation of the toxicological 
significance of any residues found in edible tissues of treated 
animals. 
5. Conclusions and recommendations 
5.1. 
The Scientific Working Group is of the opinion that the use of 
oestradì01-17/3 , testosterone and progesterone and those derivatives 
which readily yield the parent compound on hydrolysis after 
absorption from the site of application, would not present any 
harmful effects to the health of the consumer when used under the 
appropriate conditions as growth promoters in farm animals. 
5.2. 
Evaluation of the data on "trenbolone" and "zeranol" revealed that 
some data on the hormonal non-effect-level and the toxicology of 
these compounds and their metabolites are still missing. 
5.3. 
The Scientific Working Group considers it necessary that additional 
information be provided before a final conclusion can be given on 
trenbolone and zeranol. 
5.4. 
Proper programmes to control and monitor the use of anabolic agents 
are essential. 
5.5. 
It is necessary to continue scientific investigations on the releva-
nce of the present use of the "no-hormone effect" level related to 
the harmful effects of anabolic agents. 
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III. OPINION OF THE SCIENTIFIC COMMITTEES 
A. SCIENTIFIC VETERINARY COMMITTEE 
1. COMMITTEE MEMBERS : 
a) Section I : Animal Health 
P.H. BOOL 
M.K. ESKILDSEN 
R. FARINE 
J. LEUNEN 
Β. LIESS 
J.B. McFERRAN 
C. MEURIER 
D.J. O'REILLY 
O. PAPADOPOULOS 
V. PAPPARELLA 
W. PLOWRIGHT 
GH. SCHLIESSER 
B. TOMA 
b) Section II : Public Health 
G. CUMONT 
M. DEBACKERE 
F. KENNY 
P.S. ELIAS 
R.J. GILBERT 
D. GROSSKLAUS 
E.H. KAMPELMACHER 
CH. LABIE 
G.E. LAMMING 
A. MANDIS 
F. PANEBIANCO 
C. RING 
N.P. SKOVGAARD 
R. VIVIANI 
2. OPINION 
"The Committee unanimously agreed that it fully supports the 
conclusions and recommendations of the report of the Commission 
Scientific Group. 
However, the Committee attracted the attention of the Commission to 
the urgent need for further discussion and action to establish : 
(a) the conditions of use, 
(b) methods of analysis, 
(c) monitoring programmes, 
as regards these substances." 
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Β. SCIENTIFIC COMMITTEE ON ANIMAL NUTRITION 
1. COMMITTEE MEMBERS : 
D.G. ARMSTRONG H. HEIGENER 
G. BALLARINI S. MALETTO 
G. BORIES B. BREST NEILSEN 
p. DORN M.M. MCALEESE 
V. ELEZOGLOU M. VANBELLE 
P.S. ELIAS G.J. VAN ESCH 
R. FERRANDO M. WOODBINE 
G. GEDEK 
OPINION 
"The Committee has examined the report by the Commission's scientific 
working group on anabolic agents used in livestock production and has 
approved its conclusions and recommendations. 
The Committee, however, wishes to draw the Commission's attention to 
the need to lay down certain essential provisions, in particular as 
regards the following : 
a) Instructions for use 
1. Specification of the doses, the type of pharmaceutical 
preparation, the number and frequency of administrations. 
2. Association of anabolic agents. 
3. Localization of implant and ablation of zone treated. 
4. Withdrawal period before slaughter. 
5. Identification of animals treated, with indication of the 
period of treatment. 
b) Surveillance programme and analysis methods 
1. Control of production and trade in anabolic agents. 
2. Veterinary control of authorized uses. 
3. Means and methods of control." 
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C. SCIENTIFIC COMMITTEE FOR FOOD 
1. COMMITTEE MEMBERS 
P.S. ELIAS A. POLYCHRONOPOULOU-TRICHOPOULOU 
A. HILDEBRANDT E. POULSEN 
F. HILL J. REY 
A.W. HUBBARD V. SILANO 
Α. LAFONTAINE R. TRUHAUT 
Β. MAcGIBBON G.J. VAN ESCH 
A. MARIANI R. WENNIG 
K.J. NETTER 
The Committee gave its opinion at its meeting of the 4 February 1983. 
Terms of Reference 
To give an opinion on whether the use for fattening purposes in 
animals of the following substances : oestradiol -17^, testosterone, 
progesterone, trenbolone and zeranol present any harmful effect to 
health. 
Background 
On the 31 July 1981 the Council adopted Directive 81/602/EEC 
concerning the prohibition of certain substances having a hormonal 
action and of any substance having a thyrostatic action. 
By Article 5 of that Directive the Council decided to take a decision 
as soon as possible on the administering to farm animals of 
oestradiol -17/?, testosterone, progesterone, trenbolone and zeranol, 
for fattening purposes. It also noted the Commission's intention to 
consult the competent Scientific Committees on the matter. 
The Commission asked the Scientific Veterinary Committee, the 
Scientific Committee for Animal Nutrition and the Scientific 
Committee for Food the same question, recognizing that the three 
committees would lay emphasis in their separate reports on the 
aspects of the question which fell within their terms of reference. 
The three Committees established a joint working group composed of 
members of the committees with special knowledge of the subject. 
A number of eminent specialists in the field joined the working group 
which met several times under the auspices of the Commission Services 
as a "scientific working group on anabolic agents in animal 
production". 
(1) OJ No L 222 of 07.08.1981, p. 32 
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The Scientific Committee for Food, together with the Scientific 
Committee for Animal Nutrition and Scientific Veterinary Committee, 
was requested to consider the report of the Scientific Working Group 
and to comment on its conclusions and recommendations during the 
Committee's own review. 
The committee has been informed that the Commission intends to make 
public the report of the Scientific Working Group. The Committee 
also notes that the Scientific Veterinary Committee and the 
Scientific Committee for Animal Nutrition have both already made 
recommendations to the Commission on the proper use of these anabolic 
agents. 
Current Review 
The Committee is impressed by the thoroughness with which the report 
of the joint working group has been prepared. There appears no 
reason in the present report to reherse all the reasoning included 
therein, particularly in view of its imminent publication. 
The conclusions of the Scientific Working Group were as follows : 
1. The Scientific Working Group is of the opinion that the use of 
oestradiol -17/?, testosterone and progesterone, and those deriva-
tives which readily yield the parent compound on hydrolysis after 
absorption from the site of application, would not present any 
harmful effects to the health of the consumer when used under the 
appropriate conditions as growth promoters in farm animals. 
2. Evaluation of the data on "trenbolone" and "zeranol" revealed that 
some data on the hormonal no-effect level and the toxicology of 
these compounds and their metabolites are still missing. 
3. The Scientific Working Group considers it necessary that additio-
nal information be provided before a final conclusion can be given 
on trenbolone and zeranol. 
4. Proper programmes to control and monitor the use of anabolic 
agents are essential. 
5. It is necessary to continue scientific investigations on the 
relevance of the present use of the "no-hormone effect" level when 
related to the harmful effects of anabolic agents. 
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Conclusions and Recommendations 
In general, the Scientific Committee for Food agrees with the 
conclusions and recommendations of the Scientific Working Group. It 
also wishes to put forward the following comments for consideration 
by the Commission : 
i) In relation to Recommendation 2 it would be of interest to 
generate data on the threshold values for the toxic and hormo-
nal activities of trenbolone and zeranol. 
ii) The Committee endorses the Recommendation 4 on the importance 
of implementing programmes for control and monitoring of anabo-
lic agents. It emphasizes that proposals should be made by the 
Commission for implementation. In connection with this aim it 
would be necessary to encourage the development and standardi-
sation of appropriate analytical methods. 
iii) The Committee recognises that the possible misuse of naturally 
occurring hormones or their derivatives, which easily yield the 
original hormone, may be difficult to detect analytically. 
Information is therefore needed on the levels of naturally 
occurring hormones likely to engender a health hazard. It is 
an important public health consideration to prevent the illegal 
use of banned products and the misuse of authorised products by 
efficient monitoring and proper controls. 
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On the 31 July 1981 the Council adopted Directive 81/602/EEC' concerning the 
prohibition of certain substances having a hormonal action and of any substance 
having a thyrostatic action. 
By Article 5 of that directive the Council decided to take a decision as soon as 
possible on the administering to farm animals of oestradiol 17/3, testosterone, 
progesterone, trenbolone and zeranol, for fattening purposes. It also noted the 
Commission's intention to consult the competent scientific committees on the 
matter. 
The Commission asked the Scientific Veterinary Committee, the Scientific Committee 
for Animal Nutrition and the Scientific Committee for Food the question: 'Does the 
use for fattening purposes in animals of the following substances: oestradiol 17/3, 
testosterone, progesterone, trenbolone and zeranol present any harmful effect to 
health?' 
To facilitate this work a specific scientific group was created in which representatives 
of each of the scientific committees participated. 
This document contains the report adopted by the scientific group as a result of its 
final meeting of 22 September 1982. This report was made available to the scientific 
committees whose opinion was requested. 
The Scientific Veterinary Committee gave its opinion at its 5th meeting on 9 
November 1982. 
The Scientific Committee on Animal Nutrition gave its opinion at its 33rd meeting on 
17 November 1982. 
The Scientific Committee for Food gave its opinion at its 39th meeting on 4 February 
1983. 
OJ L222, 7.8.1981, p.32. 
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